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Background and purpose: Stroke is the third cause of death worldwide. In recent decade there
has been a marked progress in treatment and prevention of stroke, which was possible
largely due to modern neuroimaging techniques. Early radiological conﬁrmation of the
diagnosis allows for introduction of ﬁbrinolytic therapy and evaluation of ischaemic pen-
umbra.
Material and methods: We have analysed clinical and imaging data of 92 patients with early
stages of stroke. The sensitivity, speciﬁcity and possible inﬂuence on the choice of treatment
were assessed for different neuroimaging techniques, including diffusion weighted and
perfusion imaging in patients with hyperacute and acute stroke.
Results: A non-contrast computed tomography (CT) allowed for the detection of early
ischaemic changes with an overall sensitivity of 38% and 42% in patients in hyperacute
phase. In a perfusion CT study the perfusion abnormalities in the area corresponding to the
clinical symptoms were present in 79% of patients. The sensitivity of diffusion weighted
imaging (DWI) alone was 95% and in conjunction with perfusion MR reached 100%.
Conclusions: Our study proves that advanced neuroimaging modalities allow for a substan-
tial increase of sensitivity when detecting changes in patients with acute ischaemic strokes
and conﬁrming the clinical diagnosis. We believe that MR in combination with DWI should
be the imaging methods of choice in diagnosing acute stroke patients. Perfusion adds
signiﬁcant diagnostic value to structural techniques, particularly in clinically ambiguous
cases. In cases with a clear clinical picture the data provided by a non-contrast CT study is
sufﬁcient for therapeutic decision making.
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According to data published by AHA/ASA (American Heart
Association/American Stroke Association) in 2008 on the basis
of EROS (European Registers of Stroke), cerebral strokes occur
in 141 men and 94 women per 100 000 European citizens.
Ischaemic strokes represent up to 80% of all cases of stroke
[1,2]. About 70 000 patients suffer from stroke every year in
Poland and about 30 000 of them die, which makes this disease
the third cause of death in the country. Stroke is also the main
cause of disability – about 70% of patients after stroke are
permanently incapable of independent living.
Despite the fact that stroke morbidity in Poland has
remained unchanged for the past twenty years, the mortality
rate has decreased signiﬁcantly [2]. This positive trend is
mainly the result of latest achievements in the ﬁelds of
treatment and secondary prevention. Introduction of throm-
bolytic therapy was a break-through in treatment of strokes,
but it can only be applied during the ﬁrst 4.5 h from the onset of
symptoms. Unfortunately, in many patients the diagnosis is
established too late for those latest treatments to be intro-
duced. For this reason the application of new imaging
techniques which will guide the therapeutical decision
making process is crucial for patients with early strokes.
It is worth stressing that computed tomography and
magnetic resonance are equivalent modalities in stroke
imaging and their advantages and disadvantages have been
widely discussed in literature.
Computed tomography is still considered the best ﬁrst-line
modality in patients with acute strokes according to various
guidelines [3–7]. Computed tomography without contrast
enhancement is a very effective imaging method for differen-
tiating between acute ischaemic and haemorrhagic strokes but
its sensitivity in detecting early ischaemic changes is limited [
9,11–16]. Perfusion computed tomography of the brain, which
allows for the assessment of cerebral blood ﬂow, has been
becoming increasingly widely used lately [17–23].
Magnetic resonance imaging is an alternative imaging
modality often used in patients presenting with early strokes.
A thorough stroke protocol should include diffusion weighted
imaging (DWI), which allows for the detection of early
ischaemic changes with very high sensitivity, FLAIR Images
– which provide anatomical reference images and help in
differentiating between a stroke and stroke mimics, and help
to rule out a subarachnoid haemorrhage, a gradient echo T2*
sequence allowing for the detection of intracerebral haemor-
rhages and haemorrhagic transformation of an ischaemic
stroke, and a 3D-TOF angiography for establishing the severity
of vascular obstruction [24–30]. Magnetic resonance perfusion
imaging allows for the assessment of cerebral blood ﬂow
parameters. A combination of diffusion and perfusion imaging
makes it possible to establish the size of the infarct core and
ischaemic penumbra [35,38,41,43]. Data from recent literature
suggests a correlation between the size of those areas, called
the diffusion–perfusion mismatch, and the prognosis of
patients suffering from ischaemic strokes. The size of an
ischaemic penumbra seems to also possess predictive value in
patients treated with thrombolytic therapy and may be helpful
in therapeutic decision making [31–39].In 2010 the American Academy of Neurology (AAN)
published guidelines which stood in opposition to European
guidelines and found magnetic resonance imaging superior to
computed tomography. Its authors recommended that all
patients with a clinical suspicion of an acute stroke and
symptoms persisting for less than 12 h should undergo MR
imaging [8]. This recommendation results mainly from the
much higher sensitivity of diffusion weighted imaging in
comparison with computed tomography in detecting early
ischaemic changes. The signiﬁcance of a morphological
conﬁrmation of an ischaemic lesion is also stressed by the
authors of the new deﬁnition of stroke proposed by the AHA/
ASA experts [48]. On the other hand, the guidelines regarding
acute stroke management published in 2013 by experts of the
same society name computed tomography as the ﬁrst-line
modality that is sufﬁcient for therapeutic decision making.
They also state that in some cases perfusion imaging (pCT,
pMR) can be used in patients who are outside the therapeutic
time window to qualify them for intravenous thrombolysis [7].
2. Materials and methods
We analysed clinical courses and neuroimaging data of 92
patients with acute strokes who fulﬁlled the criteria listed
below:
- clinical symptoms of an early stroke – up to 24 h from their
onset;
- no contraindications for intravenous iodine contrast admin-
istration or MR imaging and gadolinium contrast adminis-
tration in patients undergoing MR examination;
- age above 18 years; informed consent; and
- clinical diagnosis of an early stroke.
Patients were admitted to the Stroke Wards in Warsaw in
years 2010–2013. On admission all patients were evaluated by a
neurologist. The evaluation included an assessment of
neurological condition according to NIHSS (National Institute
of Health Stroke Scale). Coexisting stroke risk factors were
considered. A basic panel of blood tests was performed
including: morphology, biochemistry, lipid proﬁle, coagulo-
gram, thyroid hormones level, and urinalysis. Electrocardiog-
raphy, echocardiography, chest radiograph, and carotid
arteries Doppler ultrasound were also performed.
Patients were divided into groups depending on the type of
imaging tests they underwent:
Group I: non-contrast computed tomography was per-
formed on admission, followed by an MRI with DWI sequence
up to 30 min after the CT. The group consisted of 42 patients,
including 14 in the hyperacute phase.
Group II: non-contrast CT and CT perfusion were performed
on admission, followed by a control MRI or CT examinations
(depending on the patient's condition). The group consisted of
29 patients, including 17 in the hyperacute phase.
The second group was further divided into three subgroups:
II a – patients treated with intravenous thrombolysis with
signiﬁcant ischaemic penumbra (10 patients) – Fig. 4;
II b – patients disqualiﬁed from thrombolytic treatment
with signiﬁcant ischaemic penumbra (9 patients);
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without signiﬁcant ischaemic penumbra (9 patients) – Fig. 5.
A group of patients treated with rtPA without an ischaemic
penumbra was not distinguished because it would have
consisted of only one patient.
An ischaemic penumbra was deﬁned as an area of
perfusion abnormalities exceeding 20% of the decreased
relative CBV area. In each group clinical improvement was
evaluated using the NIHSS scale. Improvement was deﬁned as
a difference between the number of points on admission and
on the day of discharge (usually after 7–9 days).
Group III: MRI and MR perfusion were performed on
admission, followed by control MRI or CT examinations
(depending on the patient's condition). The group consisted
of 21 patients including 7 people in the hyperacute phase.
There were 8 patients with causes for neurological deﬁcit
such as: a haemorrhagic stroke, Bell palsy and Hakim
syndrome. Those patients were not included in the analysis.
The hyperacute phase of stroke was deﬁned as symptoms
lasting no longer than 6 h. Changes in the brain's parenchyma
as well as cerebral vessels' hyperdensity in CT scans were
considered to be the markers of an early ischaemic stroke. In
perfusion tests hypoperfusion was deﬁned as an area of
prolonged mean transit time (MTT) and decreased cerebral
blood ﬂow (CBF). Cut-off values of relative MTT over 150% and
relative CBF under 56% in comparison with the opposite side
were assumed [44,45].
2.1. Computed tomography and magnetic resonance
protocols
Computed tomography studies were conducted using a 16-
row scanner (GE BrightSpeed 16 Slice CT, General Electric)
and a 32-row scanner (GE LightSpeed 32 Slice CT, General
Electric). Axial images with slice thickness of 2.5 mm were
obtained using sequential technique. CT perfusion exam-
inations were performed according to a standard protocol
recommended by the manufacturer: after choosing a
reference plane at the level of basal ganglia, 40 ml of a
370 mg/ml concentrated iodine contrast were administered
at a rate of 4 ml/s followed by a 20 ml saline ﬂush. Images
were interpreted using Perfusion4 software on a GE
work station. The imaging protocol was uniﬁed for both
Departments.
The MR studies were conducted on a 1.5 T Toshiba Excelart
Vantage scanner. The protocol included DWI (TR/TE 6000/
95 ms, b = 0 and b = 1000 s/mm2), diffusion tensor imaging
(DTI), spin echo T1 weighted images (TR/TE 650/17 ms), FLAIRTable 1 – Group I – characteristics and results.
Patients wit
stroke (0–
Number of patients 42 
Mean NIHSS on admission 6.3 
Mean NIHSS at discharge 3.5 
Mean time from the symptoms onset to imaging 4.98
Number of patients with symptoms present in NCECT 16 
Number of patients with symptoms present in MR 41 sequence (TR/TE 8000/105 ms; TI 2500 ms), and gradient echo
T2*-weighted images (TR/TE 700/15 ms). Some of them were
conducted on a 1.5 T Philips Achieva Neo Dual scanner: DWI
(TR/TE 2900/62 ms, b = 0 and b = 1000 s/mm2), diffusion tensor
imaging (DTI), and FLAIR sequence (TR/TE 1100/140 ms; TI
2800 ms). MR perfusion studies were performed using the DSC
technique (dynamic susceptibility contrast).
Images were acquired after an intravenous administration
of 20 ml of 0.5 M gadolinium contrast agent administered at a
rate of 5 ml/s followed by a 20 ml saline ﬂush at the same rate.
Images were interpreted using Brain Magix software imple-
mented by engineers from the Warsaw University of Technol-
ogy and Imagylis company.
2.2. Results interpretation and evaluation
All tests were interpreted independently by two neuroradiol-
ogists and two neurologists with at least 5 years of experience
in neuroimaging studies interpretation. In cases of discordant
opinions a ﬁnal decision was made by an independent
consultant. In the ﬁrst group the interpreters of CT examina-
tions were blinded to the results of the MR studies conducted
immediately after the CT scan. Authors ﬁnd this model
resembled the radiologists' every-day practice the closest. In
each group the imaging markers of early stroke were
evaluated. Patients with ischaemic changes within the
anterior and posterior vascular territories as well as with
lacunar strokes were included in the study.
3. Results
The sensitivity of different imaging modalities was compared.
In the ﬁrst group (Tables 1 and 2) ischaemic changes in
computed tomography were present in 16 out of 42 patients
(sensitivity of 38.10% CI: 23.58–54.36%) – Fig. 1. Ischaemic
lesions in a control MR study were observed in 41 out of 42
patients in this group (sensitivity of 97.62% CI: 87.39–99.60%)
(Fig. 2).
As for the hyperacute stage (6 h after symptoms onset),
imaging symptoms of stroke were visible in 6 out of 14 patients
(sensitivity of 42.86% CI: 17.76–71.08%) in CT studies and in 13
out of 14 patients (sensitivity of 92.86% CI: 66.06–98.81%) in MR
scans (Fig. 3).
In the acute stage ischaemic changes were present in 10
out of 28 patients in CT (sensitivity of 35.71% CI: 18.67–
55.93%) and in all patients in the MR (sensitivity of 100% CI:
87.54–100%) tests.h early
24 h)
Patients with hyperacute
stroke (0–6 h)
Patients with acute
stroke (6–24 h)
14 28
6.8 5.4
3.9 3.3
 2.9 8.75
6 10
13 28
Table 2 – Group I – correlation between clinical condition and radiological symptoms.
Lesion present in
CT and MR
Lesion present only in
MR (DWI)
Mean NIHSS on admission – therapeutic time window for i.v. rtPA 14.2 6.4
Mean NIHSS on admission – hyperacute phase 7 4.4
Mean NIHSS on admission – early stroke (up to 24 h) 6.3 4.1
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of thrombolytic therapy the clinical symptoms resolved and
no ischaemic changes were present in the control MR study.
In the second group (Table 3) in a pCT study perfusion
abnormalities in an area corresponding to the clinical
symptoms were present in 23 out of 29 patients (sensitivity
of 79.31% CI: 60.27–99.21%). In the hyperacute and acute stages
the sensitivity was 94.12% (CI: 71.24–99.02%) and 58.33% (CI:
27.75–84.68%) respectively (Fig. 6).
Among the patients who did not present with perfusion
deﬁcits in perfusion tests one had ischaemic lesions localised
in the brainstem, while the rest showed small peripheral foci.
In patients treated with intravenous rtPA (group IIa) the
average improvement reached 7.2 pts (SE = 0.88) and it was theFig. 1 – 65-year-old patient with visual disturbances lasting for 11
(a); an MR examination confirmed that an area of restricted diffu
Fig. 2 – 74-year-old patient presented with left-sided paraparesi
hyperdense right middle cerebral artery and right temporal pole
noncontrast CT performed 5 h after the symptoms' onset (a). Diff
right insula, posterior limb of the right internal capsule (b and c)
control CT scan performed 6 days later (d) revealed vast ischaem
increased density of cerebral cortex is consistent with a luxury highest among all groups. Patients with ischaemic penumbras
who were not treated with thrombolysis (group IIb) improved
by 5.7 pts (SE = 1.53), and those without a signiﬁcant penumbra
(group IIc) by 2.8 pts (SE = 0.44).
In the third group (Table 4) the MR diffusion and perfusion
imaging was performed on admission. Ten patients presented
with hyperacute strokes. The diffusion restriction was present
in 20 out of 21 patients – sensitivity 95.24% (CI: 76.11–99.21%).
In the hyperacute and acute stages the sensitivity was 90% (CI:
55.46–98.34%) and 100% (CI: 71.33–100%) respectively.
In one patient examined after 4 h from the symptoms'
onset only perfusion abnormalities were present without any
diffusion restriction. After the treatment a follow up exam
revealed a small ischaemic lesion with diffusion restriction. h. A hypodense lesion is present in a noncontrast CT study
sion indicating early ischaemic changes was present (b–d).
s, left-sided hemianopsia and hemispatial neglect. A
 grey-white matter differentiation loss are present in a
usion restriction is present in the cortical grey matter of the
 and anterior part of the right temporal lobe (not shown). A
ic changes originating from the RMCA supply area. The
perfusion.
Fig. 3 – No perceptible ischaemic changes are present in the noncontrast CT scan (a) of a 64-year-old patient with a left leg
weakness persisting for 8 h. A small ischaemic lesion can be observed in the posterior limb of the right internal capsule:
diffusion restriction in DWI sequence (b and c) and a poorly differentiated area of an increased signal in FLAIR (d) are present.
Fig. 4 – 67-year-old patient presenting with symptoms of early stroke. No changes present in noncontrast CT study (a). In a
perfusion CT study, however, an area of decreased CBV – infarct core (b) and a vast area of prolonged MTT – ischaemic
penumbra (c) and a decreased CBF (d) are present.
Fig. 5 – No changes were present in a noncontrast CT (a) of a 70-year-old patient with a right-sided weakness lasting for 4.5 h.
A perfusion CT examination revealed abnormal perfusion parameters within the left temporal lobe – the CBF (b), MTT (c),
CBV (d).
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Table 3 – Group II – characteristics and results.
Patients with early
stroke (0–24 h)
Patients with hyperacute
stroke (0–6 h)
Patients with acute
stroke (6–24 h)
Number of patients 29 17 12
Mean NIHSS on admission 8.3 9.1 7.1
Mean NIHSS at discharge 3 2.4 4.1
Mean time from the symptoms onset to imaging 4 2.96 9.6
Number of patients with symptoms present in NCECT 11 7 4
Number of patients with symptoms present in pCT 23 16 7
Fig. 6 – A patient with clinical symptoms of a hyperacute
ischaemic stroke. Restricted diffusion in the area supplied
by LACA is present (a). An area of perfusion abnormalities is
not significantly larger than the infarct core (b – CBV, c –
MTT), no PDM (perfusion–diffusion mismatch) is present (d).
Table 4 – Group II – hyperacute and acute phase (for 24 h).
With penumbra
>20%; without
thrombolytic therapy
Without signiﬁcant
penumbra (<20%); without
thrombolytic therapy
With penumbra
>20%; with thrombolytic
therapy
Number of patients 9 9 10
Mean NIHSS on admission 9.3 5.1 9.7
Mean NIHSS at discharge 3.5 2.4 2.5
Difference of NIHSS between the admission
and the discharge
5.7 2.3 7.2
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conﬁrm the diagnosis in all cases – sensitivity reached 100%
(CI: 83.75–100%).
In one patient with an ischaemic lesion of the pons no
perfusion abnormalities were observed. In two patients with
lacunar strokes the MTT prolongation was the only perfusion
abnormality. Ischaemic penumbra was present in 14 out of 21
patients with early strokes (Fig. 7).
4. Discussion
Unenhanced computed tomography was revealed to be the
least sensitive imaging modality in the studied group; it only
allowed for a conﬁrmation of a diagnosis of an early ischaemic
stroke in 38% of patients and 42% of patients in the hyperacute
phase. MRI diffusion imaging was characterised by very high
sensitivity and allowed for a recognition of early ischaemic
changes as areas of restricted diffusion in 95% of patients. For
this reason authors think that MR should be the imaging
modality of choice for diagnosing patients with clinical
symptoms of ischaemic strokes in hyperacute and acute
stages. However, in patients initially qualiﬁed for intravenous
thrombolysis, MR should only be conducted on the condition
that it does not delay the introduction of treatment.
Adding perfusion imaging to a noncontrast CT exam
increased the sensitivity of conﬁrming ischaemic changes
up to 79% by depicting an area of perfusion disturbance
corresponding with the clinical symptoms. This fact makes it
an effective method of conﬁrming the ischaemic aetiology of a
neurological deﬁcit, particularly in patients with an unclear
clinical picture. This applies also to MR perfusion imaging,
which allows for a highly adequate outline of the infarct core
and the ischaemic penumbra if combined with diffusion
imaging. In the view of recently published results of clinical
trials regarding prolongation of the therapeutic window for the
administration of intravenous thrombolysis in patients with
Fig. 7 – An 80-year-old patient with a left-sided weakness
and aphasia lasting for 4 h; diffusion restriction within the
left temporal lobe is present (a and b). In a perfusion MR
study an area of decreased CBV (c and d) and a much larger
area of prolonged MTT (e and f) are present – relevant PDM
(perfusion–diffusion mismatch) (g).
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mismatch this imaging approach may become a standard
procedure. However, further studies in this ﬁeld are required.
The combination of DWI and PWI techniques allowed for a
conﬁrmation of ischaemic strokes in all patients in group III.
Advanced imaging modalities in early ischaemic strokes
were also evaluated in terms of their prognostic value. In the
second group, during short clinical observation, patients with
signiﬁcant ischaemic penumbra recovered better in compari-
son to those without the mismatch. The results suggest thatthe neurological deﬁcit that presented in patients with early
strokes may be partly a result of reversible changes.
Non-contrast CT has been the go-to imaging technique in
testing patients with early ischaemic strokes for years.
Advantages of this modality include short acquisition time,
low cost, wide availability, long experience in using this
method and high sensitivity in excluding haemorrhagic
changes. Nevertheless, a non-contrast CT scan of the brain
is of insufﬁcient sensitivity in diagnosing and characterising
ischaemic lesions in early phases, which has been proven by
other authors [24–26] and conﬁrmed by this study. Radiological
signs of early strokes are only seen in approximately 60% of
patients and they are usually associated with severe paren-
chymal injuries or large cerebral vessel occlusions. For this
reason therapeutic decisions are often made without a
radiological conﬁrmation of the diagnosis. This is particularly
crucial in patients with ambiguous clinical symptoms who
may potentially qualify for the thrombolytic therapy – patients
with ischaemic strokes may beneﬁt from this therapy but it is
associated with a high risk of complications.
Adding perfusion imaging to a non-contrast CT scan
increases signiﬁcantly the sensitivity of the method by
demonstrating perfusion abnormalities in areas correspond-
ing to the symptoms presented by the patient. However, this
modality also has its disadvantages. In our study perfusion
computed tomography was characterised by a signiﬁcantly
higher sensitivity in recognition of early ischaemic changes
when compared with that of a non-contrast CT, although it
gave false negative results if the ischaemic lesion was localised
outside the imaged volume. The study may also result in false
negatives in cases of early spontaneous reperfusion; in these
cases perfusion parameters may return to normal or be only
slightly altered. The value of a perfusion CT exam is also
limited in the ﬁrst hours following the symptoms' onset when
the CBV values may remain within the normal range or
become increased as a result of vasodilatation in response to
cerebral blood ﬂow. This makes outlining the ischaemic core
and penumbra to core ratio impossible. This problem,
however, does not exist in a diffusion MR exam where the
infarct core is deﬁned by an area of restricted diffusion. A
perfusion CT study is also associated with an exposure to
iodine contrast agent and higher radiation dose, which may
become increasingly signiﬁcant in the view of the data
showing that cardiovascular events are becoming more
frequently diagnosed in patients under 40 years of age.
Nevertheless, a CT perfusion exam remains an effective
alternative in facilities where availability of magnetic reso-
nance tests is limited, as well as in treating critically ill patients
who require life support and are unable to cooperate during
examinations, and for those with contraindications to an MR
exam.
MR diffusion imaging is characterised by a very high
sensitivity in diagnosing early ischaemic changes. The
decrease in apparent diffusion coefﬁcient (ADC) allows for
the depiction of an ischaemic focus after about 20 min from
the symptoms' onset. Additional information is provided by
diffusion tensor imaging. An ischaemic focus which is
characterised by a gradual loss of cellular membranes of
neurones is characterised by a marked decrease in ADC values
and diversiﬁed changes of the fraction anisotropy (FA) values.
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assessment of an ischaemic lesion but also enables for a
quantitative deﬁnition of the phase of ischaemic changes and
depiction of the inhomogeneous character of structural
impairment in early ischaemic strokes. In conjunction with
perfusion imaging this modality may be valuable in selecting
patients for thrombolytic therapy and prediction of the
outcome in patients presenting with early strokes.
Perfusion imaging allows for a selection of patients with an
impairment of cerebral blood ﬂow who show clinical symp-
toms but without irreversible changes manifesting as a
cytotoxic oedema. Many authors also suggest a predictive
value of perfusion imaging. This tendency is also present in
the group of patients tested with perfusion CT. Patients
without mismatch showed less clinical improvement than
those with a signiﬁcant penumbra. We hypothesise that this
phenomenon may result from the difference in origins of the
neurological deﬁcit in patients presenting without a mismatch
and those presenting with a penumbra. While the symptoms
in patients without a mismatch are the result of irreversible
changes (an infarction), the symptoms in patients presenting
with a penumbra are partially caused by a potentially
reversible hypoperfusion [40–43]. Following this hypothesis
numerous clinical trials were conducted in recent years. Their
aim was to characterise the perfusion models that are useful in
the qualiﬁcation of ischaemic stroke patients for thrombolytic
therapy. Results of the DEFUSE (Diffusion and Perfusion
Imaging Evaluation for Understanding Stroke Evolution) [32]
and EPITHET (Echoplanar Imaging Thrombolytic Evaluation)
[34,35] studies suggest that a larger mismatch area in PWI
study may be a predictor of a better therapeutic effect in
patients treated with alteplase later than 3 h after the
symptoms' onset. Similar results were published following
the DIAS and DEDAS studies [36,37] where desmoteplase was
administered between 3 and 9 h after the symptoms' onset.
Disputes were raised by the results of phase III DIAS-2 trial
which did not conﬁrm previous suspicions. A further analysis
of the data suggests that this discrepancy may have been
caused by errors made during the planning stage of the study
[38,39]. The question of the cut-off value for a clinically
relevant penumbra has also been raised recently. The majority
of authors consider a penumbra to be clinically relevant if the
penumbra to core ratio exceeds 1.2, however others suggest
that a cutoff value of 1.8–2.6 may be more appropriate while
qualifying patients for thrombolytic therapy [46,47]. Further
studies are required in order to deepen the understanding of
those issues.
Although the availability of MR is still lower than that of CT,
it is gradually improving. High ﬁeld scanners (including 3 T)
are becoming more frequent and radiologists' expertise on this
technique and interpretation it requires is increasing. MR
imaging does not use ionising radiation and can be safely
redone if a patient's condition requires monitoring and
repeated imaging. The standard stroke protocol which
includes DWI, T1 W, T2*W and FLAIR images takes only up
to 20 min to perform. The combination of diffusion and
perfusion imaging was characterised by the highest sensitivity
in the studied group. For that reason authors suggest that MR,
including diffusion weighted imaging, should be a modality of
choice in patients suspected of suffering from early stages ofischaemic strokes. MR perfusion can add signiﬁcant diagnostic
value in treating patients with unclear clinical symptoms or
those being examined close to the end of the therapeutic time
window. CT perfusion imaging was also characterised by high
sensitivity in depicting cerebral blood ﬂow disturbances and it
may be a valid alternative if MR imaging is contraindicated or
unavailable or if the time needed to perform and interpret his
test may signiﬁcantly delay the implementation of treatment.
Computed tomography will be most likely still widely used
prior to treatment implementation in clinically unambiguous
cases, as well as for excluding intracranial haemorrhages due
to its wide availability and low cost. Nevertheless, it is worth
noting that when clinical symptoms are unclear MR diffusion
and perfusion tests may add crucial data and guidance to the
therapeutic decision making.
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